The Enterprise Value as of December 2025 (TTM) for Intech Biopharm Corporation (6461.TWO) is 3.68B

According to Intech Biopharm Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 3.68B. This represents a change of -19.65% compared to the average of 4.58B of the last 4 quarters.

Intech Biopharm Corporation (6461.TWO) Historical Enterprise Value (quarterly & annually)

How has 6461.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Intech Biopharm Corporation over the last ten years is 3.93B. The current 3.68B Enterprise Value has changed 9.26% with respect to the historical average. Over the past ten years (40 quarters), 6461.TWO's Enterprise Value was at its highest in in the June 2023 quarter at 5.39B. The Enterprise Value was at its lowest in in the December 2022 quarter at 3.76B.

Intech Biopharm Corporation (6461.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Intech Biopharm Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Intech Biopharm Corporation (6461.TWO) Average Enterprise Value

How has 6461.TWO Enterprise Value performed in the past?

The current Enterprise Value of Intech Biopharm Corporation (6461.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Intech Biopharm Corporation (6461.TWO) Enterprise Value vs. Peers

How is 6461.TWO’s Enterprise Value compared to its peers?

Intech Biopharm Corporation’s Enterprise Value is greater than Taiwan Bio Therapeutics Co., Ltd (2.09B), greater than TaiRx, Inc. (2.42B), greater than Steminent Biotherapeutics Inc. (2.77B), greater than Anti-Microbial Savior BioteQ Co., Ltd (2.48B), greater than GlycoNex Incorporation (2.21B), greater than HeXun Biosciences Co., Ltd. (2.40B), greater than Gwo Xi Stem Cell Applied Technology Co. , Ltd (2.87B), greater than Sunny Pharmtech Inc. (2.46B), greater than Sinew Pharma Inc. (2.76B), greater than Hcmed (2.28B),

Build a custom stock screener for Intech Biopharm Corporation (6461.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intech Biopharm Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Intech Biopharm Corporation (6461.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Intech Biopharm Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.